MK-801 prevents methamphetamine-induced striatal dopamine damage and reduces extracellular dopamine overflow.
O'Dell
S J
SJ
Department of Psychobiology, University of California, Irvine 92717.
Weihmuller
F B
FB
Marshall
J F
JF
D000818:Animals; D002421:Caudate Nucleus / Q000187:drug effects / Q000378:metabolism*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D016291:Dizocilpine Maleate / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005110:Extracellular Space / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008694:Methamphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009498:Neurotoxins / Q000494:pharmacology*; D011699:Putamen / Q000187:drug effects / Q000378:metabolism*; D051381:Rats
D009498:Neurotoxins; D008694:Methamphetamine; D016291:Dizocilpine Maleate; D004298:Dopamine